Pivotal Response Treatment for Autism
(PRT-HvC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the best way to deliver Pivotal Response Treatment (PRT) for young children with autism spectrum disorder (ASD) who have significant language delays. It compares the effectiveness of therapy provided at a center (Center-Based Pivotal Response Treatment, PRT-C) versus at home (Home-Based Pivotal Response Treatment, PRT-H), and includes a group receiving treatment as usual (TAU) for comparison. The trial seeks children aged 2 to 5 who have been diagnosed with ASD, experience language delays, and have a stable treatment routine. As an unphased trial, this study offers a unique opportunity to enhance understanding of the best treatment delivery methods for young children with ASD.
Will I have to stop taking my current medications?
The trial requires that participants have stable treatment, including medications, for at least 1 month before starting and no changes during the study. So, you will not have to stop taking your current medications if they have been stable.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Pivotal Response Treatment (PRT), whether conducted at a center or at home, is generally well-tolerated by young children with autism spectrum disorder (ASD). In past studies, children who received PRT made significant progress in their communication skills, and no major side effects were reported. PRT uses learning techniques to help children improve their social and communication skills. These studies found no serious negative effects, suggesting that both center-based and home-based methods are safe for children.12345
Why are researchers excited about this trial?
Researchers are excited about these treatments because they offer a personalized approach to enhancing social communication skills in children with autism. Unlike standard treatments, which often involve generic behavioral therapies, these interventions—Center-Based Pivotal Response Treatment (PRT-C) and Home-Based Pivotal Response Treatment (PRT-H)—focus on pivotal areas of a child's development, like motivation and social engagement, through targeted, play-based activities. Additionally, both interventions include parent training, which empowers families to continue the therapy at home, potentially leading to more sustainable improvements. This combination of tailored therapy and active family involvement is what makes these treatments stand out.
What evidence suggests that this trial's treatments could be effective for autism?
Research has shown that Pivotal Response Treatment (PRT) improves social communication skills in children with autism. This trial will compare two methods: center-based PRT (PRT-C) and home-based PRT (PRT-H). Studies have found that both methods significantly enhance language and social interactions. For instance, children receiving PRT often initiate conversations more frequently and communicate more effectively. Evidence suggests that PRT uses motivational techniques to encourage engagement and interaction. Furthermore, when parents receive training alongside clinicians, the positive effects increase. These findings indicate that PRT is a promising approach to enhancing social communication skills in children with autism.14678
Who Is on the Research Team?
Antonio Hardan, MD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for young children aged 2 to 5.11 years with autism spectrum disorder (ASD) and a significant language delay, who are receiving no more than an hour of speech therapy per week. They must have stable treatment for at least one month prior and be able to participate in testing procedures. Children with severe psychiatric disorders, unstable medical conditions, or those already having extensive ABA therapy are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a 16-week center-based or home-based Pivotal Response Treatment (PRT) intervention, or treatment as usual (TAU)
Follow-up
Participants are monitored for changes in social responsiveness and social functioning after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Center-Based Pivotal Response Treatment (PRT) Intervention (PRT-C)
- Home-Based Pivotal Response Treatment (PRT Intervention (PRT-H)
Center-Based Pivotal Response Treatment (PRT) Intervention (PRT-C) is already approved in United States, European Union, Canada for the following indications:
- Autism Spectrum Disorder (ASD)
- Social Communication Deficits
- Autism Spectrum Disorder (ASD)
- Social Communication Deficits
- Autism Spectrum Disorder (ASD)
- Social Communication Deficits
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
Anonymous Donor
Collaborator